Neurorehabilitation Devices Market
Neurorehabilitation Devices Market Size, Share & Trends Analysis Report by Product (Neurorobotics, Brain-Computer Interface and Non-Invasive Stimulators), by Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy and Others), and by End User (Rehabilitation Centers and Hospitals and Clinics), Forecast Period (2023-2030) Update Available - Forecast 2024-2030
Neurorehabilitation devices market is anticipated to grow at a CAGR of 13.9% during the forecast period (2023-2030). The market is driven by rising geriatric population, increasing prevalence of neurological disorders, and technological developments in neurorehabilitation devices. Multiple sclerosis, Parkinson’s disease (PD), stroke, and other disorders are among the many diseases that fall under the broad category of neurological disorders. According to the World Health Organization, global estimation in 2019 showed over 8.5 million individuals with parkinson’s disease. Current estimates suggest that, in 2019, parkinson’s disease resulted in 5.8 million disability adjusted life years (DALYs), an increase of 81% since 2000, and caused 329,000 deaths, an increase of over 100% since 2000. All these factors have compelled manufacturers to introduce novel and cutting-edge neurorehabilitation devices globally.
Segmental Outlook
The global neurorehabilitation devices market is segmented on the product, therapy area, and end user. Based on the product, the market is sub-segmented into neurorobotics, brain-computer interface and non-invasive stimulators. Based on the therapy area, the market is sub-segmented into stroke, parkinson’s disease, multiple sclerosis, cerebral palsy, and others. Further, the other includes spinal cord injury, traumatic brain injury. Further, based on end-user, the market is sub-segmented into rehabilitation centers and hospitals and clinics. Among the end-user, the hospitals and clinics sub-segment is anticipated to hold a considerable share of the market, owing to the easily accessible, offer flexible scheduling options, appealing to individuals with busy lifestyles who are seeking quick and effective treatments.
The Non-Invasive Stimulators Sub-Segment is Anticipated to Hold a Considerable Share of the Global Neurorehabilitation Devices Market
Among the product, the non-invasive stimulators sub-segment is expected to hold a considerable share of the global neurorehabilitation devices market. The segmental growth is attributed to the boosting neuropsychological or psychiatric rehabilitation, through modulation of neuroplasticity. In addition, noninvasive brain stimulation is a popular neuromodulatory technology of rehabilitation focusing on the local cerebral cortex, which improve clinical functions by regulating the excitability of corresponding neurons. The increasing number of products launching, and FDA Approval increased the acceptance of non-invasive stimulators. In May 2023, Abbott Laboratory received the US FDA approval for its spinal cord stimulation (SCS) devices for the treatment of chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain. This labeling expansion was supported by results from the DISTINCT study, which demonstrated that Abbott's proprietary BurstDR™ SCS technology improved pain levels.
Regional Outlook
The global neurorehabilitation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to the growing aging population, neurological disorders, and the rising disposable income in emerging economies are driving the neurorehabilitation devices market in the Asia Pacific.
Global Neurorehabilitation Devices Market Growth, by Region 2023-2030
The North America Region is Expected to Grow at a Significant CAGR in the Global Neurorehabilitation Devices Market
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The primary factor supporting the North America market growth includes the growing the aging population, increasing number of neurological disorders, which increases the need for neurorehabilitation equipment in Noth America. In 2022, according to the Centers for Disease Control and Prevention, every year, more than 795,000 people in the US have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Every 40 seconds, someone in the US has a stroke. Every 3 minutes and 14 seconds, someone dies of stroke. Such factors compelled the market players to expand the market in the North America. In February 2023, MindMaze launched Izar neurological rehabilitation device in US and Europe. Izar described as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral for patients with impairment in hand motor function. This proprietary peripheral is part of a comprehensive, omni-site approach to the treatment and maintenance of neurological diseases, including stroke, Parkinson’s disease, Alzheimer’s disease, and traumatic brain injury (TBI), among others.
Market Players Outlook
The major companies serving the neurorehabilitation devices market include Bioventus LLC, Ectron Corp., Hocoma AG, Medtronic Plc, Tyromotion GmbH, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2023, MYOLYN, a pioneer in medical technology company specializing in functional electrical stimulation (FES) therapy, entered a significant partnership with Shepherd Center, rehabilitation centers in the US. This partnership aimed to improve the lives of people living with paralysis by advancing rehabilitation technology, and it aligned perfectly with both organizations' shared goals.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global neurorehabilitation devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Bioventus LLC
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Ectron Corp.,
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Hocoma AG,
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Medtronic Plc,
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Tyromotion GmbH,
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Neurorehabilitation Devices Market by Type
4.1.1. Neurorobotics
4.1.2. Brain-Computer Interface
4.1.3. Non-Invasive Stimulators
4.2. Global Neurorehabilitation Devices Market by Application
4.2.1. Cardiovascular Diseases
4.2.2. Diabetes Based Surgeries
4.2.3. Transplant sites
4.2.4. Ulcers
4.2.5. Burns
4.3. Global Neurorehabilitation Devices Market by End-User
4.3.1. Hospitals
4.3.2. Ambulatory Surgery Centers
4.3.3. Specialty Clinics
4.3.4. Home Healthcare
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott Laboratories
6.2. AlterG, Inc.,
6.3. Biometrics Ltd.,
6.4. Bionik Laboratories Corp., (BNKL)
6.5. BioXtreme Ltd.,
6.6. Ekso Bionics Holdings, Inc.,
6.7. Eodyne Systems, SL
6.8. Helius Medical Technologies, Inc.,
6.9. Kinestica d.o.o.
6.10. Kinova Inc.,
6.11. Reha Technology AG
6.12. Rehab-Robotics Co., Ltd.,
6.13. Rehabtronics Inc.,
6.14. ReWalk Robotics Ltd.,
6.15. Saebo, Inc.,
1. GLOBAL NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
2. GLOBAL NEUROROBOTICS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL BRAIN-COMPUTER INTERFACE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL NON-INVASIVE STIMULATORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
5. GLOBAL NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY THERAPY AREA, 2022-2030 ($ MILLION)
6. GLOBAL NEUROREHABILITATION DEVICES FOR STROKE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL NEUROREHABILITATION DEVICES FOR PARKINSON’S DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL NEUROREHABILITATION DEVICES FOR MULTIPLE SCLEROSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL NEUROREHABILITATION DEVICES FOR CEREBRAL PALSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL NEUROREHABILITATION DEVICES FOR OTHER THERAPY AREA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
12. GLOBAL NEUROREHABILITATION DEVICES FOR REHABILITATION CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL NEUROREHABILITATION DEVICES FOR HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. GLOBAL NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
15. NORTH AMERICAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
16. NORTH AMERICAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
17. NORTH AMERICAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY THERAPY AREA, 2022-2030 ($ MILLION)
18. NORTH AMERICAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
19. EUROPEAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
20. EUROPEAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
21. EUROPEAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY THERAPY AREA, 2022-2030 ($ MILLION)
22. EUROPEAN NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
23. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
24. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
25. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY THERAPY AREA, 2022-2030 ($ MILLION)
26. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
27. REST OF THE WORLD NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
28. REST OF THE WORLD NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY THERAPY AREA, 2022-2030 ($ MILLION)
29. REST OF THE WORLD NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
1. GLOBAL NEUROREHABILITATION DEVICES MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
2. GLOBAL NEUROROBOTICS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL BRAIN-COMPUTER INTERFACE MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL NON-INVASIVE STIMULATORS MARKET SHARE BY REGION, 2022 VS 2030 (%)
5. GLOBAL NEUROREHABILITATION DEVICES MARKET SHARE BY THERAPY AREA, 2022 VS 2030 (%)
6. GLOBAL NEUROREHABILITATION DEVICES FOR STROKE MARKET SHARE BY REGION, 2022 VS 2030 (%)
7. GLOBAL NEUROREHABILITATION DEVICES FOR PARKINSON’S DISEASE MARKET SHARE BY REGION, 2022 VS 2030 (%)
8. GLOBAL NEUROREHABILITATION DEVICES FOR MULTIPLE SCLEROSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL NEUROREHABILITATION DEVICES FOR CEREBRAL PALSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL NEUROREHABILITATION DEVICES FOR OTHER THERAPY AREA MARKET SHARE BY REGION, 2022 VS 2030 (%)
11. GLOBAL NEUROREHABILITATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
12. GLOBAL NEUROREHABILITATION DEVICES FOR REHABILITATION CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. GLOBAL NEUROREHABILITATION DEVICES FOR HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
14. GLOBAL NEUROREHABILITATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
15. US NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
16. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
17. UK NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
18. FRANCE NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
19. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
20. ITALY NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
21. SPAIN NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
22. REST OF EUROPE NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
23. INDIA NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
24. CHINA NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
25. JAPAN NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
26. SOUTH KOREA NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
27. REST OF ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
28. REST OF THE WORLD NEUROREHABILITATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
